PharmaTher, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
    • Vaccines
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Newscope Capital Corporation
See more in Biomedtracker

Latest on PharmaTher, Inc.

Generics Bulletin

PharmaTher’s Ketamine Formulation Receives CRL From FDA

 
• By Adam Zamecnik

PharmaTher has received a complete response letter from the US Food and Drug Administration in response to its abbreviated new drug application for a ketamine formulation, on the grounds of minor defi

Scrip

Deal Watch: Tourmaline Will Pursue Its Thyroid Eye Disease Ambitions Following Merger With Talaris

 
• By Joseph Haas, Ian Haydock, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Talaris Calls It Quits In Reverse-Merge

Scrip

Deal Watch: BMS Returning IL-12 Candidate To Frequent Partner Dragonfly

 
• By Joseph Haas, Jung Won Shin, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap

Scrip

Tech Transfer Roundup: Tiba And CEPI Strategize Together On ‘Disease X’

 
• By Joseph Haas

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M